deltatrials

Assistance Publique Hopitaux De Marseille Clinical Trials

Sponsors / Assistance Publique Hopitaux De Marseille

Assistance Publique Hopitaux De Marseille is listed as the lead sponsor on 702 clinical trials registered with ClinicalTrials.gov. Across the portfolio, 66 are in recruitment, 10 are active non-recruiting, and 274 have reached completion. 34 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Across the portfolio, planned enrollment totals 10,935,420 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.

702
Total Trials
66
Recruiting
10
Other Active
274
Completed
34
Terminated / Withdrawn
10,935,420
Total Enrollment

Termination reasons: Other76% · Recruitment18% · Efficacy3% · Safety3%

Recent Terminations

  • NCT03900481 Phase NA Stopped May 2024
    Bariatric Surgery
    "Premature end of inclusion"
  • NCT04605848 Phase NA Stopped Oct 2023
    Paraganglioma
    "recruiting problems"
  • NCT04749901 Phase NA Stopped Jun 2023
    Epilepsy
    "Impossible to pursue the study"
  • NCT04452630 Stopped Feb 2023
    Cardiovascular Consequences After an Episode of COVID 19
    "The study was stopped because the recruitment goal could not be reached."
  • NCT04643691 Phase PHASE2 Stopped Dec 2021
    ARDS
    "due to an Urgent Security Measure"
  • NCT06909903 Phase NA Stopped Oct 2021
    Cystic Fibrosis
    "difficulty including the last participants"
  • NCT03918603 Phase NA Stopped Jun 2021
    ARDS, Human
    "mid-term analysis"
  • NCT04821973 Phase NA Stopped May 2021
    Covid19
    "the number of participants included is expected before the planned end date"
  • NCT04432805 Phase NA Stopped Jan 2021
    Pregnant Women Suspected of COVID-19
    "recruitment issues"
  • NCT04366232 Phase PHASE2 Stopped Oct 2020
    Covid-19
    "investigator decision"

Active Trials (10 total)

Top Conditions

Top Locations